Cedar Fair LP
Change company Symbol lookup
Select an option...
FUN Cedar Fair LP
NWFFX American Funds New World Fund® Class F-1
CARS Cars.com Inc
AHT Ashford Hospitality Trust Inc
AHII Fyolo Technology Corp
AHH-A Armada Hoffler Properties Inc
AHH Armada Hoffler Properties Inc
AHFD Active Health Foods Inc
AGSO AgriSolar Solutions Inc
AGS PlayAGS Inc
Go

Consumer Discretionary : Hotels, Restaurants & Leisure | Small Cap Value
Company profile

Cedar Fair, L.P. is an operator of regional amusement parks. The Company operates within a segment of amusement/water parks with accompanying resort facilities. As of December 31, 2016, the Company owned approximately 11 amusement parks, two separately gated outdoor water parks, one indoor water park and five hotels. The amusement parks include Cedar Point, located on Lake Erie between Cleveland and Toledo in Sandusky, Ohio; Knott's Berry Farm, near Los Angeles, California; Canada's Wonderland, near Toronto, Canada; Kings Island, near Cincinnati, Ohio; Carowinds, in Charlotte, North Carolina; Dorney Park & Wildwater Kingdom (Dorney Park), in Allentown, Pennsylvania; Kings Dominion, near Richmond, Virginia; California's Great America, in Santa Clara, California; Valleyfair, near Minneapolis/St. Paul, Minnesota; Worlds of Fun, in Kansas City, Missouri, and Michigan's Adventure, in Muskegon, Michigan. It manages and operates Gilroy Gardens Family Theme Park in Gilroy, California.

Closing Price
$29.90
Day's Change
0.10 (0.34%)
Bid
--
Ask
--
B/A Size
--
Day's High
30.20
Day's Low
29.25
Volume
(Below Average)
Volume:
402,329

10-day average volume:
501,475
402,329

Insulin Pens Market and COVID-19 Impact Assessment 2020-2030 Featuring Novo Nordisk, Eli Lilly & Co, Sanofi and Ypsomed - ResearchAndMarkets.com

12:43 pm ET August 11, 2020 (BusinessWire) Print

The "Insulin Pens (Diabetes Care Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.

The market model is built to visualize quantitative market trends within Diabetes Care Devices therapeutic area. This model discusses in detail the impact of COVID-19 on Insulin Pens market for the year 2020 and beyond.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Insulin Pens and evolving competitive landscape.

Insightful review of the key industry trends. Annualized total Insulin Pens market revenue by segment and market outlooks from 2015-2030. Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights.

Qualitative market specific information is available with global trends further broken down into regional trends. In addition the publisher's analysts provide unique country specific insights on the market. SWOT analysis for Insulin Pens market. Competitive dynamics insights and trends provided for Insulin Pens market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

Country specific overview of the healthcare system. Country specific reimbursement policies. Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Novo Nordisk AS, Eli Lilly and Co, Sanofi and Ypsomed Holding AG.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Reasons to Buy

The model will enable you to:

Understand the impact of COVID-19 on Insulin Pens market. Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Develop business strategies by understanding the trends shaping and driving Insulin Pens market. Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Insulin Pens market in the future. Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders. Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. Track device sales in the global and country-specific Insulin Pens market from 2015-2030. Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

For more information about this report visit https://www.researchandmarkets.com/r/7ud6m1

View source version on businesswire.com: https://www.businesswire.com/news/home/20200811005688/en/

SOURCE: Research and Markets

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.